日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular and Phenotypic Characterization of Fluid-Derived Patient-Derived Cell and Organoid Models in Advanced Gastric Cancer

晚期胃癌患者来源的体液衍生细胞和类器官模型的分子和表型特征分析

Moon, Ye Jin; Kwon, Woo Sun; Park, Chan Hee; Jang, Jinsoo; Park, Juin; Yoon, Byeong Gyu; Mun, Han Byeol; Kim, Namju; Lee, Choong-Kun; Jeung, Hei Cheul; Shin, Su-Jin; Kim, Tae Soo; Rha, Sun Young

Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial

新辅助FOLFIRINOX方案治疗可切除胰腺癌的疗效(NeoFOL-R):一项国际多中心前瞻性随机对照试验的研究方案

Jung, Hye-Sol; Choi, Julian; Park, Se Jun; Han, Youngmin; Cho, Young Jae; Yoon, Jeesun; Oh, Do-Youn; Yoon, Yoo-Seok; Kim, Jin Won; Lim, Chang-Sup; Park, Jin Hyun; Choi, In Sil; Hong, Tae Ho; Kim, Hyung Sun; Jeung, Hei-Cheul; Ahn, Keun Soo; Kim, Jin Young; Yu, Young-Dong; Kim, Ju Won; Hwang, Ho Kyoung; Lee, Choong-Kun; Choi, Hye Jin; Jung, Yun Kyung; Park, Kwonoh; Yoon, Jai Hoon; Han, In Woong; Hong, Jung Yong; Seo, Hyung Il; Do Yang, Jae; Jeon, So-Yeon; Yang, Seok Jeong; Chon, Hong Jae; Kwon, Wooil; Park, Joon Seong; Shan, Yan-Shen; Lee, Myung Ah; Jang, Jin-Young

Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial

一项评估奈拉替尼和曲妥珠单抗生物类似药治疗HER2突变晚期实体瘤患者的安全性和有效性的II期研究:KCSG AL20-17/KM23试验

Lee, Kyoungmin; Lee, Kyung-Hun; Kim, Dong-Wan; Yoon, Jeesun; Choi, Yoon Ji; Lee, Soohyeon; Kim, Ju Won; Park, Kyong Hwa; Choi, Wonyoung; Lee, Youngjoo; Ryu, Hyewon; Koo, Dong-Hoe; Lee, YunGyoo; Jeung, Hei-Cheul; Lee, Min-Young; Lee, Namsu; Kang, Myoung Joo; Lee, Jieun; Hong, Sook Hee; Kang, Eun Joo; Park, In Hae

Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13)

Varlitinib 和紫杉醇治疗 EGFR/HER2 共表达的晚期胃癌:一项多中心 Ib/II 期研究 (K-MASTER-13)

Koo, Dong-Hoe; Jung, Minkyu; Kim, Yeul Hong; Jeung, Hei-Cheul; Zang, Dae Young; Bae, Woo Kyun; Kim, Hyunki; Kim, Hyo Song; Lee, Choong-Kun; Kwon, Woo Sun; Chung, Hyun Cheol; Rha, Sun Young

Discovery of selective LATS inhibitors via scaffold hopping: enhancing drug-likeness and kinase selectivity for potential applications in regenerative medicine

通过骨架跃迁发现选择性LATS抑制剂:提高药物相似性和激酶选择性,以期在再生医学中得到应用

Issabayeva, Guldana; Kang, On-Yu; Choi, Seong Yun; Hyun, Ji Young; Park, Seong Jun; Jeung, Hei-Cheul; Lim, Hwan Jung

Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response

既往抗生素治疗会通过改变肠道菌群和全身免疫反应,干扰晚期胃癌中的抗PD-1反应。

Kim, Chang Gon; Koh, June-Young; Shin, Su-Jin; Shin, Ji-Hee; Hong, Moonki; Chung, Hyun Cheol; Rha, Sun Young; Kim, Hyo Song; Lee, Choong-Kun; Lee, Ji Hyun; Han, Yejeong; Kim, Hyoyong; Che, Xiumei; Yun, Un-Jung; Kim, Hyunki; Kim, Jee Hung; Lee, Seo Young; Park, Su Kyoung; Park, Sejung; Kim, Hyunwook; Ahn, Jin Young; Jeung, Hei-Cheul; Lee, Jeong Seok; Nam, Young-Do; Jung, Minkyu

Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis

利用 AVB-500 可溶性受体靶向 AXL 并通过基因敲除抑制胆管癌的生长和转移

Jiyoung Kim, Gilyeong Nam, You Keun Shin, Nuria Vilaplana-Lopera, Hei-Cheul Jeung, Eui Jung Moon, Ik Jae Lee

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer

一项针对晚期HER2阳性胃癌的一线治疗方案的单臂Ib/II期临床试验,研究帕博利珠单抗、曲妥珠单抗和化疗的疗效。

Lee, Choong-Kun; Rha, Sun Young; Kim, Hyo Song; Jung, Minkyu; Kang, Beodeul; Che, Jingmin; Kwon, Woo Sun; Park, Sejung; Bae, Woo Kyun; Koo, Dong-Hoe; Shin, Su-Jin; Kim, Hyunki; Jeung, Hei-Cheul; Zang, Dae Young; Lee, Sang Kil; Nam, Chung Mo; Chung, Hyun Cheol

Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis

COPB2 表达对皮肤鳞状细胞癌发病机制的影响

Taiqin Chen, Ki-Yeol Kim, Yeongjoo Oh, Hei Cheul Jeung, Kee Yang Chung, Mi Ryung Roh, Xianglan Zhang

The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients

UGT1A9*22基因型可识别胃癌患者中伊立替康毒性的高风险人群。

Lee, Choong-Kun; Chon, Hong Jae; Kwon, Woo Sun; Ban, Hyo-Jeong; Kim, Sang Cheol; Kim, Hyunwook; Jeung, Hei-Cheul; Chung, Jimyung; Rha, Sun Young